A cute infarct volume may be a useful biomarker of longterm outcomes after ischemic stroke. 1, 2 However, the data evaluating the relationship between acute infarct volume measured by diffusion-weighted imaging long-term impairment and disability have been inconsistent and conflicting. [3] [4] [5] Increasingly, patient-reported outcomes are used in clinical practice and research. The impact of acute infarct volume on health-related quality of life (HRQOL) scales has been poorly studied. 6, 7 Standard clinical tools often lack adequate assessment of day-to-day functioning. Interpreting the assessment is complicated by patients' cognitive deficiencies and functional decline. 7 The National Institute of Health has created the Neuro-Quality of Life (Neuro-QOL) scale in part to address these limitations and needs. 8 No previous studies have assessed whether acute infarct volume predicts domainspecific HRQOL. 9 We, therefore, sought to evaluate whether acute infarct volume predicts domain-specific Neuro-QOL scores at 3 months and the variance in outcomes explained by acute infarct volume.
Methods
The local institutional review board approved the study. Between August 2012 and July 2014, we prospectively enrolled consecutive patients presenting with imaging-verified ischemic stroke. Written informed consent was obtained from the patient or a legally authorized representative.
Ischemic stroke was defined as sudden onset of neurological deficits and confirmed with corresponding hyperintense and hypointense lesions on diffusion-weighted imaging and acquired diffusion coefficient (ADC) sequences, respectively. Demographics, baseline functioning, insurance status, risk factors, hospital course, discharge disposition, interval rehabilitation services, and recurrent stroke 10 were prospectively recorded. History of hypertension, diabetes mellitus, dyslipidemia, previous stroke, atrial fibrillation or flutter, and cardiac disease (history or angina, myocardial infarction, coronary bypass or intervention, or congestive heart failure) were defined by documented history, medications, or findings at presentation. Brain imaging was independently reviewed by 2 investigators (S.P. and C.L.) for the presence of acute infarction along with location and vascular territory, blinded to outcome data. Acute infarct volume was calculated by an automated algorithm using thresholds for ADC and diffusion-weighted imaging. By consensus, clinical and radiographic Background and Purpose-Limited data exist on the relationship between acute infarct volume and health-related quality of life (HRQOL) measures after ischemic stroke. We evaluated whether acute infarct volume predicts domain-specific Neuro-Quality of Life scores at 3 months after stroke. 
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Image Acquisition
Images were acquired on a 1.5-or 3-T scanner (Siemens Medical Systems, Erlangen, Germany). Axial T1 spin-echo images were used for reference. Precontrast images were preferentially used if available, otherwise postcontrast T1 images were used (typical sequence parameters: repetition time/echo time 1500/45, 13-15 slices, in-plane resolution 1.15×1.15 m, slice thickness 5 mm, field of view 22 cm, matrix 192×192, flip angle 30). Diffusion-weighted images (repetition time/echo time 4000/88, in-plane resolution 1.39×1.39 mm, slice thickness 5 mm, matrix 192×192) were acquired at B values of 0 and 1000, and ADC maps were generated inline on the scanner.
ADC Lesion Volume Calculation
Before calculating the ADC lesion volume, anatomic reference images were used to mask out any nonbrain matter. To do this, first the reference T1 image coregistered to the ADC image. Next, the T1 image was segmented into gray, white, and cerebrospinal fluid probability maps using a unified segmentation model. 13 The brain tissue mask was then defined as any voxel with >80% probability of being gray or white matter. All coregistration and segmentation was performed using SPM (SPM8; Wellcome Department of Cognitive Neurology, London, England). The final steps in lesion definition were performed in Matlab (The Mathworks Inc, Natick). After masking out all nonbrain tissue, a threshold approach to delineate the ischemic core was used.
14 Diffusion-restricted voxels were defined as any voxel with ADC <680×10 −6 mm 2 /s. To minimize noise, a minimum cluster size threshold of 0.145 mL was then applied to arrive at the final infarct volumes.
Outcome Measures
For functional outcomes, the modified Rankin Scale (mRS) was obtained using a validated telephone questionnaire at 3 months. 15 The mRS is scored from 0 (no symptoms) to 6 (dead), dichotomized between good (mRS score of ≤2) and poor outcome (mRS score of >2). We used the Neuro-QOL questionnaire, a HRQOL assessment tool for common adult neurological disorders, including stroke. 8 At 3 months, patients or their proxies completed 4 domain-specific assessments using the Neuro-QOL instrument (SF Version 1.0): upper extremity function (fine motor activity, reaching activities), lower extremity function (mobility, including walking on stairs or uneven surfaces), applied cognition-executive function (planning, organizing, calculating, working with memory and learning), and applied cognition-general concerns (perceived difficulties with abilities, such as memory, attention, and decision-making). Proxy assessments have been validated in previous studies featuring stroke populations. 10, 16 Neuro-QOL results were expressed as T scores referenced to general US population (with enrichment from a clinical neurological sample) demographics with mean 50 and SD 10 17, 18 ; additional information is available at www.neuroqol.org. 
Statistical Analysis
We calculated the means (SD) and medians (interquartile range) for continuous variables, including acute infarct volumes and HRQOL T scores in any of the 4 Neuro-QOL domains and percentages for categorical variables. Mean T scores were compared across baseline demographic, clinical, and hospital course variables using t tests. Multiple linear regression analysis was used to examine associations between acute infarct volumes and 4 domains of Neuro-QOL using T scores measured 3-month post-stroke. We developed multivariable models by sequentially adding variables that showed univariate association (P<0.10) in at least 1 domain. Covariates included in our model were age, sex, race, payor status (no insurance, government insurance [Medicaid/Medicare], or private insurance), baseline mRS before stroke, current smoking within last 6 months, past medical history of atrial fibrillation, hypertension, dyslipidemia, type 2 diabetes mellitus, previous stroke, initial NIHSS score, acute infarct volume, TOAST subtype, proxy versus patient reporting of HRQOL, discharge destination, recurrent stroke, and any rehabilitation therapy after index hospitalization. Variables known to be associated with QOL outcomes (eg, initial NIHSS, age, etc) based on previous work 10 were included in the final model regardless of univariate association. Three models were built, with each successive model repeating the adjustments of the previous model as follows: model 1 (unadjusted), model 2 (adjustment for volume groups and baseline demographics: age, sex, race, smoking, baseline mRS, past medical history, and payor status), and model 3 (model 2 plus adjustment for stroke presentation: initial NIHSS score, TOAST, proxy report, MCA territory involvement, discharge destination, ambulation at discharge, any rehabilitation after stroke, and recurrent stroke). The effect of acute infarct volume on the primary outcome (Neuro-QOL 4 domains) was evaluated with multiple linear regression of T scores at 3-month poststroke to determine the variance accounted for (variance accounted for, R 2 ) by quartile of acute infarct volume. To check linearity, associations between outcomes and predictors were plotted, and the significance of adding a quadratic term for continuous variables was assessed for each regression model. Logtransforming predictors or outcomes did not achieve linearity because of the right skewness of volume. We used acute infarct volume based on quartile (Q) groups (Q1: ≤0.30 mL; Q2: 0.31-1.20 mL; Q3: 1.20 mL-5.28 mL; Q4: >5.28 mL) in all analyses for ease of interpretation because all linear regression assumptions were not met using continuous volume measurements. Normality and constant variance of residuals were checked. Multicollinearity among predictors was checked, and all predictors in the model 3 have variance inflation factor <10.
Multivariable logistic regression was used to assess the association between acute infarct volume and other predictors with mRS at 3 months (poor 0-2 versus good 3-5) reporting the odds ratios and corresponding 95% confidence intervals. The 3 models were built similarly to the linear regression models for Neuro-QOL domains. All statistically analyses were performed using SAS 9.4 (Cary, NC). P values were 2-tailed. Statistical significance was considered to be a P value <0.05.
Results
Among 490 patients (mean age 64.2±15.86 years; 51.2% male; 63.3% White) included for analysis ( Figure) , 21 (4.3%) had recurrent stroke within 3 months, and 58 (11.8%) were disabled (mRS score of >2) at 3 months. Median acute infarct volume was 1.24 mL (interquartile range, 0.31-5.08 mL). Proxy reporting of 3-month HRQOL data was 16.9% (Table 1 ). The overall mean T scores for each HRQOL domain in each quartile of infarct volume is shown in Table I in the online-only Data Supplement. Mean T scores decrease in all domains across ascending quartiles of infarct volume.
In the unadjusted analysis (model 1), the highest quartile (>5.28 mL) volume group compared with the lowest quartile (≤0.30 mL) was associated with lower T scores for each QOL domain: upper extremity (∆T score, −4.27; P<0.0001), lower extremity (∆T score, −3.66; P=0.0034), executive function (∆T score, −3.36; P=0.0061), and general concerns (∆T score, −3.48; P<0.0001). Acute infarct volume explained only 2% to 4% of the variances in T scores by domain, with highest being 4% for applied cognition-general concerns ( 
Discussion
Acute infarct volume was associated with HRQOL domains in the unadjusted analysis. However, it only contributed modestly (33%) to prediction of a single HRQOL domain, applied cognition-general concerns, in the fully adjusted analysis. We observed that clinical and imaging factors explained only between 32% and 51% of the variance in 3-month domain-specific HRQOL scores. In contrast, the largest acute infarct volume quartile showed a significant effect on 3-month disability by mRS independent of demographic and clinical factors. These data suggest that acute infarct volume may be a modest predictor of global function and disability (eg, mRS) but provides poor discrimination of domain-specific HRQOL (eg, upper limb). Lesion location specific to the function would likely be more significant, for instance, the corticospinal tract for upper extremity function. Overall, more than half of the variance in specific domains of HRQOL is unexplained despite accounting for clinical, treatment, and imaging factors. Our data imply that other undiscovered biological, psychosocial, clinical, and imaging factors may better predict poststroke HRQOL than what is currently available.
There are conflicting data on the relationship between acute infarct volume and outcomes after stroke. 5, 7 The largest previous study done (n=108) found no significant relationship between acute infarct volume and mRS at 3 months after stroke. 19 Other smaller studies have noted that acute infarct volume can predict long-term disability. 5, 20 Schiemanck et al 6 found that infarct volume was a significant but modest predictor of long-term HRQOL (R 2 =−0.45; P<0.01) and mRS (R 2 =0.39; P<0.01). Our study results suggest that acute infarct volume is an independent predictor of global disability, as measured by mRS, but may not be as valuable in predicting domain-specific HRQOL. 
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Besides acute infarct volume, there are other imaging biomarkers that may better predict outcomes after stroke. Small studies of axonal tract and structural integrity using diffusion tensor imaging suggest strong correlation with motor outcomes 21 ; yet, HRQOL measures were not assessed. Infarct location has also shown a direct association with neurological deficits after stroke. 22 Smaller subcortical, deep white matter, internal capsule, and brain stem infarcts correlate with deficits out of proportion to the infarct volume than superficial cortical lesions. 3, 4, 7, 23 However, specific QOL domains have not been previously reported. These imaging biomarkers, and additional ones such as white matter hyperintensity, silent infarcts, and microbleeds, could be incorporated to improve future predictive models of HRQOL and disability after stroke.
HRQOL scores provide additional context for patients with poor outcomes, assess day-to-day functioning, and may even overcome ceiling effects from traditional measures, such as the mRS. 10 From previous studies, impairment in HRQOL, predicted from baseline demographics and clinical information, is common at 3 months after stroke and can even be present despite no disability on mRS and minimal deficits by NIHSS score. 10, 24 Although we confirm these previous clinical predictors, we are the first to evaluate the explained variance in HRQOL accounted for by acute infarct volume.
Although HRQOL represents an important patient-centered outcome measure, predicting HRQOL remains difficult. In adult cardiology, HRQOL data have been incorporated into heart failure clinical trials, 25 but most have shown limited prediction of HRQOL outcomes using biological variables, such as ejection fraction. In congenital heart disease, there is a high incidence of functional impairment. 26 Because shortterm mortality has been reduced, research attention has turned to long-term morbidity and HRQOL, drawing parallels to advances in stroke care. In pediatric cardiology, HRQOL has been significantly linked with physical and psychosocial domains. 26 These results reaffirm our conclusions that other psychosocial and biological variables may exist that better explain HRQOL after stroke.
A major strength of our study is the large sample size with rigorous follow-up. There are, however, several limitations. First, this study was conducted in a single urban academic institution. The differences between institutions related to magnetic resonance imaging acquisition and patient characteristics should not vary substantially, but our results may not be generalizable to all settings. Our cohort also included consecutive ischemic stroke patients, the majority of whom had mild stroke and small infarct volumes. Thus, our results may not be reflective of cohorts with large infarcts and more severe strokes. Second, besides vascular territory stratification, more specific location was not accounted for in this study. Third, Neuro-QOL measures are patient-reported outcomes. Objective measures of cognition and psychological function were not performed in this study. HRQOL assessments require active engagement with the patient. Results may be susceptible to inaccuracy if patients lose interest or tire during assessment. Fourth, not all domains of HRQOL were assessed, including fatigue and depression. Fifth, the graded response we noted between infarct volume and mRS outcomes may be because of the small sample size of those with poor outcomes and small volumes. Finally, we did not assess prestroke measures of HRQOL and are unable to report changes in T scores post-stroke. Prestroke measures of HRQOL are cumbersome to perform and not validated in hospitalized patients. Our study is the first, to our knowledge, to incorporate acute infarct volume and clinical, demographic, and hospital course into a predictive model for domain-specific HRQOL measures using Neuro-QOL in a large prospective cohort. HRQOL impairments have been shown to correlate strongly with functional disability. 23 Because HRQOL is relevant to both patients and caregivers, prediction of HRQOL after stroke warrants investigation. We found that infarct volume accounts for only a small fraction of explained variance in HRQOL measures at 3 months after ischemic stroke and is a significant predictor of only 1 domain, applied cognitiongeneral concerns. Our data imply that a broad range of factors, some known and other undiscovered, may better predict poststroke HRQOL than what is currently available. Future directions for imaging-based predictive models of HRQOL should incorporate infarct volume but also voxel-and network-based infarct location and integrity of affected tracts and structures 22 in addition to psychosocial determinants.
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